Condition: Open Angle Glaucoma · Pigmentary Glaucoma · Pseudoexfoliation Glaucoma · Sponsor: Jonathon Myers
The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.
This description comes directly from the study's public registry record.
Meskerem Divers · 215-825-4712 · mdivers@willseye.org
Jeanne L Molineaux, COA · 215-825-4713 · jmolineaux@willseye.org
Always discuss trial participation with your own doctor first.
| Wills Eye Hosital Glaucoma Dept. | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07228221